Promise of exercise in a pill as Atrogi pivots from type 2 diabetes to obesity

AI Briefing

• – Atrogi AB develops oral exercise pill ATR-258 for obesity treatment
• – ATR-258 mimics exercise effects, drives fat loss while sparing muscle
• – Overweight subjects show promising results in early trial